 | |
| Clinical data | |
|---|---|
| Other names | 6,6-Difluoro-17α-ethynyl-19-nortestosterone; 6,6-Difluoro-17α-ethynylestr-4-en-17β-ol-3-one |
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| Chemical and physical data | |
| Formula | C20H24F2O2 |
| Molar mass | 334.407 g·mol |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
6,6-Difluoronorethisterone, also known as 6,6-difluoro-17α-ethynyl-19-nortestosterone or as 6,6-difluoro-17α-ethynylestr-4-en-17β-ol-3-one, is a steroidal progestin of the 19-nortestosterone group that was described in 1971 but was never marketed. It is a fluorinated derivative of norethisterone. The C17β acetate ester, 6,6-difluoronorethisterone acetate, has also been synthesized and described.
References
- ^ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 522–. ISBN 978-1-4757-2085-3.
- Overton KH (January 1973). Terpenoids and Steroids. Royal Society of Chemistry. pp. 432–. ISBN 978-0-85186-276-7.
- Morrow DF, Gallo D (January 1972). "Steroids and Biologically Related Compounds.". In Pachter I (ed.). Annual Reports in Medicinal Chemistry. Vol. 7. Academic Press. pp. 182-193 (187). ISBN 978-0-08-058351-8.
 | This article about a steroid is a stub. You can help Misplaced Pages by expanding it. |
 | This drug article relating to the genito-urinary system is a stub. You can help Misplaced Pages by expanding it. |